Literature DB >> 20931208

Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China.

Shenghong Zhang1, Yi Cui, Bihui Zhong, Weiwei Xiao, Xiaorong Gong, Kang Chao, Minhu Chen.   

Abstract

BACKGROUND: Primary duodenal cancer (PDC) is rare and few studies have addressed it adequately, especially in China. The present study is to evaluate the clinicopathological features and prognosis of PDC in Chinese patients. PATIENTS AND METHODS: All the consecutive cases confirmed as PDC by histopathological analysis in The First Affiliated Hospital of Sun Yat-sen University between 1995 and 2008 were included. Clinicopathological details were retrospectively analysed and prognostic factors influencing survival were evaluated.
RESULTS: The patient cohort included 53 men and 38 women, accounting for only 0.02% of all in-patients during this period. Esophagogastroduodenoscopy and gastrointestinal barium radiography were mainstay diagnostic tests for PDC; they detected 88.6% and 83.3% of the tumours, respectively. Tumours mainly occurred in the descending portion of the duodenum (67.0%). Abdominal pain was the most frequent symptom (56.0%). Histologically, adenocarcinoma was the most common type (74.7%). The overall 1-, 3- and 5-year survival rates were 62.6%, 43.7% and 33.1%, respectively. Patients survived longer in the curative surgery group (median survival time of 45 months) than those in the palliative group (6 months) (P < 0.001). Nodal metastasis and positive resection margin had a significant negative impact on survival in patients undergoing potentially curative surgery in a univariate and multivariate model (P < 0.05).
CONCLUSION: Patients with PDC are rare and lack specific presentations. Esophagogastroduodenoscopy and gastrointestinal barium radiography are effective in screening this rare tumour. Nodal metastasis and positive resection margins are associated with a poor prognosis. A curative surgery that achieves complete resection with negative margin should be pursued.

Entities:  

Mesh:

Year:  2010        PMID: 20931208     DOI: 10.1007/s00384-010-1063-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  33 in total

1.  Molecular and cellular biology of small-bowel mucosa.

Authors:  Paul A. Kitchen; Julian R.F. Walters
Journal:  Curr Opin Gastroenterol       Date:  2001-03       Impact factor: 3.287

Review 2.  CT and bowel disease.

Authors:  A H Freeman
Journal:  Br J Radiol       Date:  2001-01       Impact factor: 3.039

3.  Duodenal neoplasms: predictive value of CT for determining malignancy and tumor resectability.

Authors:  E A Kazerooni; L E Quint; I R Francis
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

4.  Primary duodenal carcinoma.

Authors:  O A Adedeji; C Trescoli-Serrano; M Garcia-Zarco
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

5.  Prognostic factors for primary duodenal adenocarcinoma.

Authors:  Hyung Geun Lee; Dong Do You; Kwang Yeol Paik; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

6.  Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research.

Authors:  N Rotman; D Pezet; P L Fagniez; D Cherqui; B Celicout; P Lointier
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.

Authors:  Fu-Chih Hung; Chung-Mou Kuo; Seng-Kee Chuah; Chung-Huang Kuo; Yaw-Sen Chen; Sheng-Nan Lu; Chi-Sin Chang Chien
Journal:  J Gastroenterol Hepatol       Date:  2007-05       Impact factor: 4.029

9.  Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.

Authors:  Aaron Struck; Thomas Howard; Elena G Chiorean; Jeffrey M Clarke; Robert Riffenburgh; Higinia R Cardenes
Journal:  J Surg Oncol       Date:  2009-08-01       Impact factor: 3.454

10.  Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?

Authors:  R K Ross; N M Hartnett; L Bernstein; B E Henderson
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

View more
  14 in total

1.  Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.

Authors:  Stefano Cecchini; Camilo Correa-Gallego; Vikram Desphande; Matteo Ligorio; Abdulmetin Dursun; Jennifer Wargo; Carlos Fernàndez-del Castillo; Andrew Louis Warshaw; Cristina Rosa Ferrone
Journal:  J Gastrointest Surg       Date:  2011-10-18       Impact factor: 3.452

2.  Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma.

Authors:  Chihiro Minatsuki; Nobutake Yamamichi; Ken-Ichi Inada; Yu Takahashi; Kouhei Sakurai; Takeshi Shimamoto; Yosuke Tsuji; Kazuya Shiogama; Shinya Kodashima; Yoshiki Sakaguchi; Keiko Niimi; Satoshi Ono; Toru Niwa; Ken Ohata; Nobuyuki Matsuhashi; Masao Ichinose; Mitsuhiro Fujishiro; Yutaka Tsutsumi; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2018-06-28       Impact factor: 3.199

3.  Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.

Authors:  Giuseppe Malleo; Alfredo Tonsi; Giovanni Marchegiani; Andrea Casarotto; Salvatore Paiella; Giovanni Butturini; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2012-07-17       Impact factor: 3.445

Review 4.  Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Pipit Burasakarn; Ryota Higuchi; Souya Nunobe; Shingo Kanaji; Hidetoshi Eguchi; Ken-Ichi Okada; Tsutomu Fujii; Yuichi Nagakawa; Kengo Kanetaka; Hiroharu Yamashita; Suguru Yamada; Shinji Kuroda; Toru Aoyama; Takahiro Akahori; Kenji Nakagawa; Masakazu Yamamoto; Hiroki Yamaue; Masayuki Sho; Yasuhiro Kodera
Journal:  Int J Clin Oncol       Date:  2021-01-01       Impact factor: 3.402

Review 5.  Duodenal adenocarcinoma: Advances in diagnosis and surgical management.

Authors:  Jordan M Cloyd; Elizabeth George; Brendan C Visser
Journal:  World J Gastrointest Surg       Date:  2016-03-27

6.  Duodenal mucinous adenocarcinoma presenting as ileus, obstructive jaundice and massive ascites: A case report.

Authors:  Dongbing Ding; Yao Yao; Songbai Zhang
Journal:  Mol Clin Oncol       Date:  2018-01-11

7.  Double primary tumors-renal cell carcinoma and duodenal mucinous adenocarcinoma.

Authors:  Nada Vuckovic; Bojana Andrejic; Matilda Djolai; Srdjan Zivojinov; Katarina Sarcev; Dejan Vuckovic
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

Review 8.  Small Bowel Adenocarcinoma.

Authors:  Emerson Y Chen; Gina M Vaccaro
Journal:  Clin Colon Rectal Surg       Date:  2018-09-04

9.  Primary Duodenal Adenocarcinoma without Stenosis: A Case Report with a Brief Literature Review.

Authors:  Daisuke Usuda; Yu Hashimoto; Emiri Muranaka; Hideyuki Okamura; Tsugiyasu Kanda; Sachio Urashima
Journal:  Case Rep Oncol       Date:  2014-07-10

10.  Mixed Adenocarcinoma and Squamous Cell Carcinoma of Duodenum: A Case Report and Review of the Literature.

Authors:  Muhammad Bader Hammami; Anuj Chhaparia; Jinhua Piao; Yihua Zhou; Christine Hachem; Jinping Lai
Journal:  Case Rep Gastroenterol       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.